Abstract
Biosensors are available and applicable for detection and characterization of specific inhibitors of many enzymes. In this review, biosensors based on fixed acetylcholinesterase (AChE) or butyrylcholinesterase (BChE) are presented. Inhibition of selected enzymes by various compounds, such as organophosphorus and carbamate pesticides, nerve agents (e.g. sarin or VX), and other natural toxins (e.g. aflatoxins), was employed to develop specific assays using biosensors only. Biosensor technology brings potential miniaturization and portability, when it is compared to standard methods. Construction of biosensors based on cholinesterases became a more important issue within the last decades. Novel approach with recombinant proteins, microelectrodes and immobilization protocol related to nanotechnologies opened new insight to the cholinesterase based biosensor construction and its perspective via routine assays. This review is focused on novel trends within such biosensors as a result of the known platform.
Keywords: Biosensor, acetylcholinesterase, butyrylcholinesterase, inhibitor, organophosphate, pharmacology
Current Medicinal Chemistry
Title: Progress of Biosensors Based on Cholinesterase Inhibition
Volume: 16 Issue: 14
Author(s): Miroslav Pohanka, Kamil Musilek and Kamil Kuca
Affiliation:
Keywords: Biosensor, acetylcholinesterase, butyrylcholinesterase, inhibitor, organophosphate, pharmacology
Abstract: Biosensors are available and applicable for detection and characterization of specific inhibitors of many enzymes. In this review, biosensors based on fixed acetylcholinesterase (AChE) or butyrylcholinesterase (BChE) are presented. Inhibition of selected enzymes by various compounds, such as organophosphorus and carbamate pesticides, nerve agents (e.g. sarin or VX), and other natural toxins (e.g. aflatoxins), was employed to develop specific assays using biosensors only. Biosensor technology brings potential miniaturization and portability, when it is compared to standard methods. Construction of biosensors based on cholinesterases became a more important issue within the last decades. Novel approach with recombinant proteins, microelectrodes and immobilization protocol related to nanotechnologies opened new insight to the cholinesterase based biosensor construction and its perspective via routine assays. This review is focused on novel trends within such biosensors as a result of the known platform.
Export Options
About this article
Cite this article as:
Pohanka Miroslav, Musilek Kamil and Kuca Kamil, Progress of Biosensors Based on Cholinesterase Inhibition, Current Medicinal Chemistry 2009; 16 (14) . https://dx.doi.org/10.2174/092986709788186129
DOI https://dx.doi.org/10.2174/092986709788186129 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oligonucleotide Aptamers for Glioma Targeting: An Update
Central Nervous System Agents in Medicinal Chemistry Behcets Syndrome: Literature Review
Current Rheumatology Reviews The Gut Mucosa as a Site for Induction of Regulatory T-Cells
Current Pharmaceutical Design Genotyping OLR1 Gene: A Genomic Biomarker for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Role of the Region 23-28 in Aβ Fibril Formation: Insights from Simulations of the Monomers and Dimers of Alzheimers Peptides Aβ40 and Aβ42
Current Alzheimer Research Effects of Nicotine During Pregnancy: Human and Experimental Evidence
Current Neuropharmacology Nanostructure Engineering of ZnO Based Complex Oxides for Thermoelectric Application
Current Nanoscience Structural Analysis for Colchicine Binding Site-Targeted ATCAA Derivatives as Melanoma Antagonists
Medicinal Chemistry Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity
Current Pharmaceutical Design Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases
Current Drug Targets Roles of CLR/RAMP Receptor Signaling in Reproduction and Development
Current Protein & Peptide Science Neuroanatomical and Neurophysiological Abnormalities in the Neural Correlates of Face Processing in Schizophrenia
Current Psychiatry Reviews Melatonin and Its Therapeutic Potential in Neuroprotection
Central Nervous System Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Neuropharmacology Biosynthesized Quantum Dots as Improved Biocompatible Tools for Biomedical Applications
Current Medicinal Chemistry Antibiotic Treatment in Native Valve Infective Endocarditis
Infectious Disorders - Drug Targets Comprehensive Assessment of Compliance with Antimuscarinic Drug Treatment in the Case of Urge Urinary Incontinence of Older Patients
Current Aging Science Commentary: ADHD and Substance Abuse
Adolescent Psychiatry Age-Dependent Changes of the temporal Order - Causes and Treatment
Current Aging Science